Utah-based Intermountain Healthcare and the Icelandic company deCODE Genetics are teaming up on a deep dive into the DNA of half a million patients, a collaboration they hope can reveal connections between the makeup of our genomes and our health.

The partnership, announced Wednesday and dubbed the HerediGene: Population Study, aims to analyze the genomes of 500,000 patients from Intermountain’s network of clinics and hospitals in Utah and Idaho. Scientists and clinical experts from deCODE and Intermountain will compare the genomic data with patients’ medical histories to gain a better understanding of how our genes influence our health.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy